FdaApplication
ANDA 213034
Identifiers
- fda_app_no: ANDA213034
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD |
| application_type | ANDA |
| approval_date | 2020-01-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DROSPIRENONE AND ETHINYL ESTRADIOL | DROSPIRENONE; ETHINYL ESTRADIOL | 3MG;0.03MG | TABLET;ORAL-28 |
1 product